GNOM vs. CNCR ETF Comparison

Comparison of Global X Genomics & Biotechnology ETF (GNOM) to Loncar Cancer Immunotherapy ETF (CNCR)
GNOM

Global X Genomics & Biotechnology ETF

GNOM Description

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$10.49

Average Daily Volume

36,331

Number of Holdings *

39

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$14.74

Average Daily Volume

3,771

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period GNOM CNCR
30 Days -5.50% 0.07%
60 Days -7.82% -2.25%
90 Days -5.32% 3.58%
12 Months 13.65% 45.65%
6 Overlapping Holdings
Symbol Grade Weight in GNOM Weight in CNCR Overlap
ALLO D 0.48% 1.35% 0.48%
BNTX B 4.77% 1.21% 1.21%
CRBU D 0.26% 1.28% 0.26%
LEGN F 3.76% 1.16% 1.16%
LYEL F 0.2% 1.25% 0.2%
TSVT D 0.43% 1.42% 0.43%
GNOM Overweight 33 Positions Relative to CNCR
Symbol Grade Weight
ALNY C 7.52%
RNA C 6.04%
NTRA B 4.88%
RARE D 4.62%
VCYT A 4.58%
ILMN A 4.39%
TECH B 4.11%
SRPT D 4.01%
QGEN D 3.8%
A D 3.6%
MYGN F 3.48%
ARWR F 3.28%
CRSP C 3.24%
BMRN F 2.91%
NTLA F 2.82%
BEAM F 2.74%
RCKT F 2.69%
GILD A 2.52%
VRTX D 2.25%
TXG F 2.14%
CDNA D 2.06%
MRNA F 1.85%
VIR B 1.25%
PACB C 0.85%
SANA F 0.84%
RGNX F 0.77%
FLGT C 0.72%
VERV C 0.61%
QURE B 0.52%
EDIT F 0.48%
PSTX D 0.33%
BLUE F 0.17%
SCLX D 0.01%
GNOM Underweight 61 Positions Relative to CNCR
Symbol Grade Weight
BMEA D -1.91%
TYRA F -1.89%
ELVN B -1.75%
HCM C -1.74%
ACLX B -1.55%
REPL B -1.55%
MGNX C -1.55%
YMAB A -1.54%
AURA B -1.54%
AUTL D -1.51%
KPTI C -1.5%
RVMD A -1.47%
BMY A -1.43%
DAWN A -1.42%
ARVN C -1.42%
MRUS C -1.41%
MRSN D -1.41%
JANX A -1.4%
EXEL A -1.39%
RPTX C -1.39%
RCUS F -1.38%
IGMS B -1.37%
BCYC D -1.37%
SNDX F -1.37%
KYMR C -1.36%
XNCR A -1.35%
IOVA B -1.35%
GNLX C -1.32%
BPMC C -1.32%
ACRV B -1.32%
IMCR F -1.31%
NRIX B -1.31%
ACET F -1.3%
STRO D -1.28%
RXRX F -1.28%
PGEN F -1.27%
GERN C -1.26%
CGEM F -1.24%
SDGR F -1.23%
RAPT D -1.23%
ERAS C -1.23%
MRK F -1.22%
ZNTL D -1.22%
IPHA D -1.18%
GLUE A -1.17%
GMAB F -1.15%
NUVL D -1.13%
FHTX C -1.11%
REGN F -1.1%
KURA F -1.1%
SWTX D -1.09%
IDYA F -1.08%
RLAY F -1.05%
FATE F -1.03%
IMRX D -1.02%
NUVB F -1.02%
ITOS F -0.99%
IMTX F -0.99%
VOR D -0.94%
SMMT C -0.92%
PRLD F -0.85%
Compare ETFs